Mapping the cancer patient journey with liquid biopsy

Pancreatic cancer cells with blue nuclei forming a sphere surrounded by red membranes in a lab setting. [Credit: National Cancer Institute]

According to the American Cancer Society, one in two men and one in three women will be diagnosed with cancer at some point in their lives. Patients seek treatment to shrink their tumors and ideally achieve remission; however, there is no one-size-fits-all approach. At its core, cancer is a genetic disease: Different types of cancer that affect specific organs or systems can share genetic qualities, but every individual can also carry unique mutations that affect how their tumor behaves. Therefore, molecular testing has a critical role to play in all stages of cancer treatment, from developing new drugs to delivering these as treatments. 

The promise of molecular testing approaches

Over the years, increasingly complex molecular testing approaches have gained favor in the fie…

Read more
  • 0